Cargando…
Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens
We describe here the development of stable classical and El Tor V. cholerae O1 strains of the Hikojima serotype that co–express the Inaba and Ogawa antigens of O1 lipopolysaccharide (LPS). Mutation of the wbeT gene reduced LPS perosamine methylation and thereby gave only partial transformation into...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232259/ https://www.ncbi.nlm.nih.gov/pubmed/25397871 http://dx.doi.org/10.1371/journal.pone.0108521 |
_version_ | 1782344538096926720 |
---|---|
author | Karlsson, Stefan L. Ax, Elisabeth Nygren, Erik Källgård, Susanne Blomquist, Margareta Ekman, Annelie Benktander, John Holmgren, Jan Lebens, Michael |
author_facet | Karlsson, Stefan L. Ax, Elisabeth Nygren, Erik Källgård, Susanne Blomquist, Margareta Ekman, Annelie Benktander, John Holmgren, Jan Lebens, Michael |
author_sort | Karlsson, Stefan L. |
collection | PubMed |
description | We describe here the development of stable classical and El Tor V. cholerae O1 strains of the Hikojima serotype that co–express the Inaba and Ogawa antigens of O1 lipopolysaccharide (LPS). Mutation of the wbeT gene reduced LPS perosamine methylation and thereby gave only partial transformation into Ogawa LPS on the cell surface. The strains express approximately equal amounts of Inaba– and Ogawa–LPS antigens which are preserved after formalin–inactivation of the bacteria. Oral immunizations of both inbred and outbred mice with formalin–inactivated whole–cell vaccine preparations of these strains elicited strong intestinal IgA anti–LPS as well as serum vibriocidal antibody responses against both Inaba and Ogawa that were fully comparable to the responses induced by the licensed Dukoral vaccine. Passive protection studies in infant mice showed that immune sera raised against either of the novel Hikojima vaccine strains protected baby mice against infection with virulent strains of both serotypes. This study illustrates the power of using genetic manipulation to improve the properties of bacteria strains for use in killed whole–cell vaccines. |
format | Online Article Text |
id | pubmed-4232259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-42322592014-11-26 Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens Karlsson, Stefan L. Ax, Elisabeth Nygren, Erik Källgård, Susanne Blomquist, Margareta Ekman, Annelie Benktander, John Holmgren, Jan Lebens, Michael PLoS One Research Article We describe here the development of stable classical and El Tor V. cholerae O1 strains of the Hikojima serotype that co–express the Inaba and Ogawa antigens of O1 lipopolysaccharide (LPS). Mutation of the wbeT gene reduced LPS perosamine methylation and thereby gave only partial transformation into Ogawa LPS on the cell surface. The strains express approximately equal amounts of Inaba– and Ogawa–LPS antigens which are preserved after formalin–inactivation of the bacteria. Oral immunizations of both inbred and outbred mice with formalin–inactivated whole–cell vaccine preparations of these strains elicited strong intestinal IgA anti–LPS as well as serum vibriocidal antibody responses against both Inaba and Ogawa that were fully comparable to the responses induced by the licensed Dukoral vaccine. Passive protection studies in infant mice showed that immune sera raised against either of the novel Hikojima vaccine strains protected baby mice against infection with virulent strains of both serotypes. This study illustrates the power of using genetic manipulation to improve the properties of bacteria strains for use in killed whole–cell vaccines. Public Library of Science 2014-11-14 /pmc/articles/PMC4232259/ /pubmed/25397871 http://dx.doi.org/10.1371/journal.pone.0108521 Text en © 2014 Karlsson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Karlsson, Stefan L. Ax, Elisabeth Nygren, Erik Källgård, Susanne Blomquist, Margareta Ekman, Annelie Benktander, John Holmgren, Jan Lebens, Michael Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens |
title | Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens |
title_full | Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens |
title_fullStr | Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens |
title_full_unstemmed | Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens |
title_short | Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens |
title_sort | development of stable vibrio cholerae o1 hikojima type vaccine strains co–expressing the inaba and ogawa lipopolysaccharide antigens |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232259/ https://www.ncbi.nlm.nih.gov/pubmed/25397871 http://dx.doi.org/10.1371/journal.pone.0108521 |
work_keys_str_mv | AT karlssonstefanl developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens AT axelisabeth developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens AT nygrenerik developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens AT kallgardsusanne developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens AT blomquistmargareta developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens AT ekmanannelie developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens AT benktanderjohn developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens AT holmgrenjan developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens AT lebensmichael developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens |